207 related articles for article (PubMed ID: 27256996)
1. Complete response and long-term survival of leptomeningeal carcinomatosis from breast cancer with maintenance endocrine therapy.
Almajed MM; Esfahani K; Pelmus M; Panasci L
BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27256996
[TBL] [Abstract][Full Text] [Related]
2. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
3. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
[TBL] [Abstract][Full Text] [Related]
4. Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab.
Oliveira M; Braga S; Passos-Coelho JL; Fonseca R; Oliveira J
Breast Cancer Res Treat; 2011 Jun; 127(3):841-4. PubMed ID: 21369716
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
Mego M; Sycova-Mila Z; Obertova J; Rajec J; Liskova S; Palacka P; Porsok S; Mardiak J
Breast; 2011 Oct; 20(5):478-80. PubMed ID: 21700455
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival in an untreated patient with leptomeningeal carcinomatosis from breast primary.
Singh SK; Bansal VK; Wiley EL; Valyi-Nagy T; Villano JL
Clin Neurol Neurosurg; 2013 Mar; 115(3):362-4. PubMed ID: 22727367
[No Abstract] [Full Text] [Related]
7. [Intrathecal methotrexate in breast cancer meningeal carcinomatosis - Experience with a new administration schedule].
Cochereau D; Da Costa S; Le Maignan C; Gauthier H; Cochereau J; Espié M; Giacchetti S; Teixeira L
Bull Cancer; 2016 May; 103(5):444-54. PubMed ID: 26987841
[TBL] [Abstract][Full Text] [Related]
8. [Effective systemic palliative chemotherapy for intracranial metastases of breast cancer].
Sipőcz I; Pintér T; Skaliczky Z; Kullmann T
Orv Hetil; 2016 Nov; 157(45):1809-1813. PubMed ID: 27817234
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis.
Park WY; Kim HJ; Kim K; Bae SB; Lee N; Lee KT; Won JH; Park HS; Lee SC
Cancer Res Treat; 2016 Apr; 48(2):843-7. PubMed ID: 25761487
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal carcinomatosis of gastric adenocarcinoma.
Bulut G; Erden A; Karaca B; Göker E
Turk J Gastroenterol; 2011; 22(2):195-8. PubMed ID: 21796558
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V
Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096
[TBL] [Abstract][Full Text] [Related]
12. Prolonged survival of neoplastic meningitis from breast cancer with letrozole and intrathecal methotrexate: a case report.
Peroukides S; Onyenadum A; Starakis I; Koutras A; Makatsoris T; Bouboukas G; Kalofonos H
J Neurooncol; 2011 Feb; 101(3):509-11. PubMed ID: 20563832
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid cytology diagnosis of HER2-positive leptomeningeal carcinomatosis from HER2-positive metastatic gastric cancer: case report.
Cavanna L; Rocchi A; Gorgni S; Ambroggi M; Foroni RP; Ubbiali A; Civardi G
J Clin Oncol; 2011 May; 29(13):e367-8. PubMed ID: 21300922
[No Abstract] [Full Text] [Related]
14. Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis.
Chen IC; Lin CH; Jan IS; Cheng AL; Lu YS
J Formos Med Assoc; 2016 Apr; 115(4):243-8. PubMed ID: 25890495
[TBL] [Abstract][Full Text] [Related]
15. Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin.
Salgia S; Fleming GF; Lukas RV
J Clin Neurosci; 2014 Jul; 21(7):1250-1. PubMed ID: 24412296
[TBL] [Abstract][Full Text] [Related]
16. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
[TBL] [Abstract][Full Text] [Related]
17. Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study.
Scott BJ; van Vugt VA; Rush T; Brown T; Chen CC; Carter BS; Schwab R; Fanta P; Helsten T; Bazhenova L; Parker B; Pingle S; Saria MG; Brown BD; Piccioni DE; Kesari S
J Neurooncol; 2014 Sep; 119(2):361-8. PubMed ID: 24942463
[TBL] [Abstract][Full Text] [Related]
18. Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report.
Gaviani P; Silvani A; Corsini E; Erbetta A; Salmaggi A
Neurol Sci; 2009 Jun; 30(3):251-4. PubMed ID: 19259616
[TBL] [Abstract][Full Text] [Related]
19. Complete response of leptomeningeal carcinomatosis secondary to breast cancer.
Troussier I; Canova C; Klausner G
Breast; 2020 Dec; 54():328-330. PubMed ID: 33278649
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis.
Wu PF; Lin CH; Kuo CH; Chen WW; Yeh DC; Liao HW; Huang SM; Cheng AL; Lu YS
BMC Cancer; 2015 Apr; 15():299. PubMed ID: 25928457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]